Eisai Aims To Expand Generics Business In Japan
This article was originally published in PharmAsia News
Executive Summary
Eisai Senior VP for Japanese Business Hideshi Honda said the company aims to expand generic drugs business to ¥20 billion, or five percent of total sales by 2013